Front Row Advisors LLC Dr Reddys Laboratories LTD Transaction History

Front Row Advisors LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 30, 2020	SELL	$51.39 - $72.41 $5,241 - $7,385	-102 Closed	0 $0
Q2 2020 Aug 17, 2020	BUY	$39.55 - $54.65 $1,146 - $1,584	29 Added 39.73%	102 $5,000
Q1 2020 May 08, 2020	SELL	$34.75 - $45.85 $2,710 - $3,576	-78 Reduced 51.66%	73 $4,000
Q4 2019 Feb 14, 2020	SELL	$36.66 - $41.78 $36 - $41	-1 Reduced 0.66%	151 $6,000
Q3 2019 Nov 08, 2019	BUY	$34.82 - $39.26 $1,357 - $1,531	39 Added 34.51%	152 $6,000
Q2 2019 Aug 27, 2019	BUY	$36.05 - $42.76 $865 - $1,026	24 Added 26.97%	113 $4,000
Q1 2019 May 17, 2019	BUY	$35.77 - $40.57 $2,897 - $3,286	81 Added 1012.5%	89 $4,000
Q4 2018 Feb 13, 2019	BUY	$31.89 - $38.44 $255 - $307	8 New	8 $0

251

94M

Ticker RDY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 166,028,992
Market Cap $2.29B
Description
Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...

Get notified when there are updates to the investment portfolio of Front Row Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Front Row Advisors LLC with notifications on news.